Abstract:Objectives Tissue inhibitor of metalloproteinases-1 (TIMP-1) is considered to play a key role in the development of pulmonary arterial hypertension (PAH). However, the molecular regulatory mechanisms of TIMP-1 in the pulmonary arteries were not very clear, especially in the human pulmonary arterial smooth muscle cells (HPASMCs). This study try to investigate the signalling pathway involved in the regulation of TIMP-1 in HPASMCs stimulated with transforming growth factor (TGF)-β1. Methods Cultured HPASMCs were incubated with different concentrations of TGF-β1 (0, 2.5, 5, 10, 20 or 40 ng/ml) for 24 h, or with 10 ng/ml TGF-β1 for different time (1, 4, 8, 12, 24 or 48 h). Western blot and real-time PCR were employed to detect the protein and mRNA expression of TIMP-1 in HPASMCs, and enzyme-linked immuno sorbent assay (ELISA) was used to detect the secretion of TIMP-1 in the culture medium. Then, the activities of three mitogen-activated protein kinases (MAPK), including extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and c-Jun NH2-terminal kinase (JNK), were respectively inhibited with their specific inhibitors, U0126, SB202190 and SP600125. The protein and mRNA of TIMP-1 were also detected to help distinguishing that which kinase was involved in the regulation of TIMP-1 in HPASMCs induced by TGF-β1. Besides this, mithramycin, a specific inhibitor of Sp1 transcription factor, and curcumin, a specific inhibitor of activator protein-1 (AP-1), were used to block the DNA-binding activity of Sp1 or AP-1 respectively. And electrophoretic mobility shift assay (EMSA), Western blot and real-time PCR were carried out to help confirming that which transcription factor was involved in the regulation of TIMP-1 in HPASMCs. Results Western blot, real-time PCR and ELISA analysis showed that TGF-β1 could time- and dose-dependently enhance the expression and secretion of TIMP-1. Furthermore, TGF-β1 could phosphorylate two kinases of MAPK, ERK1/2 and p38, but not JNK, and the phosphorylation of p38 was weaker compared with ERK1/2. Of these kinases, only the inhibition of ERK 1/2 by U0126 effectively blocked the TGF-β1-induced expression of TIMP-1. Mithramycin also significantly reduced the expression of TIMP-1 via blocking the DNA-binding activity of Sp1. However, the inhibition of AP-1 by curcumin couldn't achieve this result. Additionally, the results of EMSA showed that TGF-β1 could up-regulate the DNA-binding activity of Sp1, and that U0126 and mithramycin could effectively suppressed this activation in a dose-dependent manner. Conclusions TGF-β1 could time- and dose-dependently stimulate the expression and secretion of TIMP-1 in HPASMCs, and ERK1/2 and Sp1 signalling pathways might be involved in these activities.

Sphk1/S1p Mediates Tgf-Beta 1-Induced Proliferation Of Pulmonary Artery Smooth Muscle Cells And Its Potential Mechanisms

SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation Via Mir-21/Bmprii/id1 Signaling Pathway

ACTIVATION OF ERK 1/2 AND SP1 MAY CONTRIBUTE TO THE EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 INDUCED BY TRANSFORMING GROWTH FACTOR-β1 IN HUMAN PULMONARY ARTERIAL SMOOTH MUSCLE CELLS

S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation

Sphingosine-1-phosphate promotes pulmonary artery smooth muscle cells proliferation by stimulating autophagy-mediated E-cadherin/CDH1 down-regulation

Activation of Yes‐associated Protein Mediates Sphingosine‐1‐phosphate–induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Its Potential Mechanisms

Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

PKC and TGF-β1 expressions in pulmonary artery of pulmonary hypertension rats and regulation of 5-HT2A receptor antagonist on them

SIRT1 Mediates Sphk1/S1P-induced Proliferation and Migration of Endothelial Cells.

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension

5-HT Induces PPAR Γ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells Via Modulating GSK-3β/β-catenin Pathway

S150 Smad-dependent and Smad-independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells in Vitro and in Vivo

Leukotriene B4 Induces Proliferation of Rat Pulmonary Arterial Smooth Muscle Cells Via Modulating GSK-3β/β-catenin Pathway.

S1P induces pulmonary artery smooth muscle cell proliferation by activating calcineurin/NFAT/OPN signaling pathway.

Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms

Effect of Sphingosine 1-Phosphate (S1P) on Proliferation of Human Fetal Lung Fibroblasts

Over-expression of PKGIα Inhibits Hypoxia-Induced Proliferation, Akt Activation, and Phenotype Modulation of Human PASMCs: the Role of Phenotype Modulation of PASMCs in Pulmonary Vascular Remodeling.

Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension

Cited2 Inhibited Hypoxia-Induced Proliferation and Migration of PASMCs Via the TGF-β1/Cited2/PPARγ Pathway.

Sphingosine-1-phosphate Induces Airway Smooth Muscle Cell Proliferation, Migration, and Contraction by Modulating Hippo Signaling Effector YAP.